Anti-CD26 monoclonal antibodies can reversibly arrest human T lymphocytes in the late G1 phase of the cell cycle
- 30 June 1993
- journal article
- Published by Elsevier in Immunobiology
- Vol. 188 (1-2) , 36-50
- https://doi.org/10.1016/s0171-2985(11)80485-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Expression of CD26 (Dipeptidyl Peptidase IV) on Resting and Activated Human T‐LymphocytesScandinavian Journal of Immunology, 1991
- Differential regulation of lymphokine production by distinct subunits of the T cell interleukin 2 receptor.Journal of Clinical Investigation, 1991
- Induction of interleukin 2 (IL2) and interferon-γ and enhancement of IL2 receptor expression by a CD26 monoclonal antibodyEuropean Journal of Immunology, 1991
- CD26 Antigen is a Surface Dipeptidyl Peptidase IV (DPPIV) as Characterized by Monoclonal Antibodies Clone Til‐19‐4‐7 and 4EL1C7Scandinavian Journal of Immunology, 1990
- FcR-mediated crosslinking of Ta1 (CDw26) induces human T lymphocyte activationCellular Immunology, 1990
- Influence of human T lymphocytes identified by antibodies to dipeptidyl peptidase IV on differentiation of human B lymphocytes stimulated with Staphylococcus aureus cowan I and pokeweed mitogenCellular Immunology, 1988
- Differential expression of T cell differentiation antigens and major histocompatibility antigens on activated T cells during the cell cycleEuropean Journal of Immunology, 1986
- Triggering of the lethal hit in human cytotoxic T lymphocytes: a functional role for a 103‐kDa T cell‐ specific activation antigenEuropean Journal of Immunology, 1986
- Interleukin 2 production by human T lymphocytes identified by antibodies to dipeptidyl peptidase IVCellular Immunology, 1985
- A rapid method for the isolation of functional thymus‐derived murine lymphocytesEuropean Journal of Immunology, 1973